Literature DB >> 15252524

Anionic carbonato and oxalato cobalt(III) nitrogen mustard complexes.

Peter R Craig1, Penelope J Brothers, George R Clark, William R Wilson, William A Denny, David C Ware.   

Abstract

Synthetic approaches to cobalt(III) complexes [Co(L)(L')2] containing the bidentate dialkylating nitrogen mustard N,N-bis(2-chloroethyl)-1,2-ethanediamine (L = dce) together with anionic ancilliary ligands (L') which are either carbonato (CO3(2-)), oxalato (ox2-), bis(2-hydroxyethyl)dithiocarbamato (bhedtc-), 2-pyridine carboxylato (pico-) or 2-pyrazine carboxylato (pyzc-) were investigated. Synthetic routes were developed using the related amines N,N-diethyl-1,2-ethanediamine (dee) and 1,2-ethanediamine (en). The complexes [Co(CO3)2(L)]- (L = dee 1, dce 2), [Co(ox)2(L)]- (L = dee 3, dce 4), [Co(bhedtc)2(dee)]+ 5, [Co(bhedtc)2(en)]+ 6, mer-[Co(pico)3], mer-[Co(pyzc)]3 7 and [Co(pico)2(dee)]+ 8 were prepared and were characterised by IR, UV-Vis, 1H and 13C[1H] NMR spectroscopy, mass spectrometry and cyclic voltammetry. [Co(bhedtc)2(en)]BPh4 6b and trans(O)-[Co(pico)2(dee)]ClO4 8 were characterised by X-ray crystallography. In vitro biological tests were carried out on complexes 1-4 in order to assess the degree to which coordination of the mustard to cobalt attenuated its cytotoxicity, and the differential toxicity in air vs. nitrogen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15252524     DOI: 10.1039/b311091e

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

Review 1.  Redox activation of metal-based prodrugs as a strategy for drug delivery.

Authors:  Nora Graf; Stephen J Lippard
Journal:  Adv Drug Deliv Rev       Date:  2012-01-25       Impact factor: 15.470

2.  Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs.

Authors:  Marlene Mathuber; Hemma Schueffl; Orsolya Dömötör; Claudia Karnthaler; Éva A Enyedy; Petra Heffeter; Bernhard K Keppler; Christian R Kowol
Journal:  Inorg Chem       Date:  2020-11-21       Impact factor: 5.165

3.  Development of a cobalt(iii)-based ponatinib prodrug system.

Authors:  Marlene Mathuber; Michael Gutmann; Mery La Franca; Petra Vician; Anna Laemmerer; Patrick Moser; Bernhard K Keppler; Walter Berger; Christian R Kowol
Journal:  Inorg Chem Front       Date:  2021-03-30       Impact factor: 6.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.